Your Control Has to Contain Everything Except the Peptide

A control is supposed to be the experiment minus the thing you are testing. In practice it is often the experiment minus the thing you are testing and minus several things nobody counted as variables — a different final solvent percentage, a different container, a different number of hours standing on the bench. Each of those omissions has a documented effect in the published literature, and the most instructive one does not add noise. It inverts the answer.

Quick answer

What belongs in a vehicle control? Everything in the test condition except the peptide, at the same amounts, for the same duration, in the same container. That means the solvent at its exact final percentage, any preservative in the diluent, any surfactant or excipient, the buffer and its pH, the same container material and geometry, the same contact time and temperature, and the same freeze-thaw history. The reason this matters more than it sounds: a 2025 study found that DMSO at low concentrations was cytoprotective and growth-promoting, and that this effect caused the test substance's toxicity to be underestimated. An unmatched control did not merely blur the result; it pushed it the wrong way.

The failure mode nobody expects

The intuition about solvents and additives is that they are either inert or harmful. On that model, a clean-looking result is trustworthy and only a toxic-looking result needs a solvent control to rule out an artefact.

The data contradict that. In a study across seven brain cell types, low DMSO concentrations in the range 0.0156–0.0625% produced hormetic cytoprotective and growth-promoting effects, while concentrations at or above 2% were cytotoxic. Because the low-concentration effect was protective, the apparent toxicity of the substance under test was suppressed, and the authors concluded its toxicity may have been underestimated as a result. Their stated conclusion was that rigorous solvent controls are crucial to separate genuine substance effects from solvent confounds and avoid erroneous interpretations.

So a protective vehicle effect makes an active substance look inert. Nothing in the readout flags it, and the direction of the error is the one least likely to prompt a second look. We cover the solvent itself in DMSO in peptide work.

Everything else in the liquid has a documented effect too

None of these are exotic. They are the ordinary contents of an ordinary working solution, and each one has a literature showing it is not inert.

The dilution series problem

This is the most common way a well-intentioned control fails.

A test series is usually made by diluting one concentrated stock. If that stock is in DMSO, or carries a preservative or excipient, then the amount of vehicle carried into each well varies across the series — highest at the top concentration, lowest at the bottom. A single vehicle control therefore matches exactly one point of the curve and misrepresents every other.

Worse, because the vehicle effect may itself be non-monotonic, the mismatch is not a constant offset you can subtract. The shape of the dose-response can be distorted rather than shifted.

Matching more than composition

Composition is the obvious part. These are the parts people skip:

• Duration. Toxicity of solvents tracks exposure time as well as concentration. A control that sat for one hour does not control for a test that sat for a day.
• Container. Leachable migration is time- and temperature-dependent, and adsorptive loss depends on surface-to-volume ratio. A control in a glass tube does not control for a test in plastic — see adsorption to surfaces.
• Solvent lot and bottle. DMSO is hygroscopic and its water content drifts with use. The control should share the test's solvent history, not come from a fresh bottle.
• Freeze-thaw history. If the test material was thawed twice, the vehicle should have been too. See aliquoting and freeze-thaw cycles.
• Preparation path. Reaching 0.1% by diluting a concentrated stock is not identical to preparing 0.1% directly, if anything precipitated or adsorbed along the way.
• Filtration. If the test solution was filtered, the control should be filtered through the same membrane — both for the membrane's extractables and because filtration removes material.

A short checklist before the run

• List every component of the test condition, including things you did not deliberately add: container, septum, filter, diluent preservative.
• Confirm the vehicle control contains each one at the same amount.
• Check whether the vehicle percentage varies across the series. If it does, either normalise it or control each point.
• Match duration, temperature, container and freeze-thaw history, not only composition.
• Use the same solvent bottle and the same consumable brand for both.
• Write all of it down. An unrecorded additive is an unreproducible experiment, which is the same argument made for materials in lot-to-lot variability.

Why this is worth the trouble

Because the alternative is a result that cannot be attributed. If the peptide condition differs from the control and the two differ in four ways, the experiment has not isolated anything — and the published cases above show the confound can be larger than the effect being measured, and can point the other way.

None of this requires extra instrumentation or a change in method. It requires treating the vehicle as a real condition with its own composition and history, rather than as the absence of a condition.

Key takeaways

• A no-peptide well is not automatically a vehicle control. The vehicle is everything except the peptide.
• Low-concentration DMSO was cytoprotective and growth-promoting, causing a test substance's toxicity to be underestimated. An unmatched control can invert a conclusion, not just blur it.
• Preservatives, surfactants, excipients and container leachables all have documented effects and all belong in the control.
• In a dilution series the vehicle percentage usually varies across the series, so one control matches one point. Normalise the vehicle or control every point.
• Match duration, temperature, container, solvent lot, freeze-thaw history and preparation path — not only composition.
• If the test was filtered, filter the control through the same membrane.
• Record every component. An unrecorded additive makes the experiment unreproducible.

Frequently asked questions

Is a buffer-only well enough?

Only if the buffer is genuinely the whole vehicle. If the peptide arrived via a DMSO stock, or the diluent was bacteriostatic rather than plain water, or an excipient was added, then the buffer-only well is missing components that have documented effects.

My DMSO is below 0.1%. Do I still need a matched control?

Yes, and that range is precisely where the hormetic effects were reported. The low end is not a safe zone where matching stops mattering; in the cited work it is where the confound was largest relative to the signal.

Does this apply to purely analytical work?

The biological part does not, but the chemistry does. A blank for an absorbance measurement must contain the same diluent, preservative and additives, or the baseline is wrong. See measuring peptide concentration.

What if I cannot match the container?

Then record the difference and treat it as a known limitation rather than ignoring it. Where a container difference is unavoidable, running both arms in both containers separates the container effect from the peptide effect, at the cost of twice the conditions.

Does bacteriostatic water need to be in the control?

If the test solution was made with it, yes. Benzyl alcohol has its own documented activity, and the control should contain it at the same concentration. The comparison between diluents is in bacteriostatic versus sterile water.

Sources

• Fu Y, Zhang J, Yang C, Wang Y, Yang Y, Qiu P, Xie W, Zhang S, Lǒ T. Effects of solvent dimethyl sulfoxide invites a rethink of its application in amyloid beta cytotoxicity. Int J Toxicol. 2025;44(4):297–313. DOI
• Ahmadkhani N, Sugden C, Benson JD, Eroglu A, Higgins AZ. High-throughput evaluation of cryoprotective agents for mixture effects that reduce toxicity. Cryobiology. 2025;121:105316. DOI
• Hammond M, Nunn H, Rogers G, et al. Identification of a leachable compound detrimental to cell growth in single-use bioprocess containers. PDA J Pharm Sci Technol. 2013;67(2):123–34. DOI
• Hutchings RL, Singh SM, Cabello-Villegas J, Mallela KMG. Effect of antimicrobial preservatives on partial protein unfolding and aggregation. J Pharm Sci. 2013;102(2):365–76. DOI
• Svilenov HL, Kopp KT, Golovanov AP, Winter G, Zalar M. Insights into the stabilization of interferon alpha by two surfactants revealed by STD-NMR spectroscopy. J Pharm Sci. 2023;112(2):404–410. DOI

Citations retrieved via PubMed. These studies were performed on cultured cells and therapeutic proteins; the mechanisms transfer, the specific values do not.

This article describes experimental design and laboratory practice only. It contains no usage instructions, no dosing information and no protocols of any kind.

For laboratory and in-vitro research use only. Not for human or veterinary use.